VO(2peak) is markedly impaired in breast cancer survivors and may serve as an independent predictor of survival in metastatic disease.
Patients with breast cancer have marked impairment in VO(2peak) across the entire survivorship continuum. VO(2peak) may be an independent predictor of survival in metastatic disease.
Jones et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: